-
Symbol
-
MLTX on Nasdaq
-
Investment type
-
Equity / Class A ordinary share, par value $0.0001 per share
-
Latest Disclosed Shares Owned
-
19,751,284 shares
-
Security Ownership %
-
28%
BVF PARTNERS L P/IL ownership in MoonLake Immunotherapeutics Class A ordinary share, par value $0.0001 per share (MLTX)
10 Nov 2025 - BVF PARTNERS L P/IL has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 19,751,284 shares of MoonLake Immunotherapeutics Class A ordinary share, par value $0.0001 per share (MLTX).
This represents 28% ownership of the company.
This is the first filing by BIOTECHNOLOGY VALUE FUND L P disclosing ownership of MoonLake Immunotherapeutics Class A ordinary share, par value $0.0001 per share (MLTX).